The BCLI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BCLI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BCLI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BCLI Detailed Price Forecast - CNN Money||View BCLI Detailed Summary - Google Finance|
|View BCLI Detailed Summary - Yahoo! Finance||View BCLI Stock Research & Analysis - Zacks.com|
|View BCLI Trends & Analysis - Trade-Ideas||View BCLI Major Holders - Barrons|
|View BCLI Call Transcripts - NASDAQ||View BCLI Breaking News & Analysis - Seeking Alpha|
|View BCLI Annual Report - CompanySpotlight.com||View BCLI OTC Short Report - OTCShortReport.com|
|View BCLI Fundamentals - TradeKing||View BCLI SEC Filings - Bar Chart|
|View Historical Prices for BCLI - The WSJ||View Performance/Total Return for BCLI - Morningstar|
|View the Analyst Estimates for BCLI - MarketWatch||View the Earnings History for BCLI - CNBC|
|View the BCLI Earnings - StockMarketWatch||View BCLI Buy or Sell Recommendations - MacroAxis|
|View the BCLI Bullish Patterns - American Bulls||View BCLI Short Pain Metrics - ShortPainBot.com|
|View BCLI Stock Mentions - StockTwits||View BCLI Stock Mentions - PennyStockTweets|
|View BCLI Stock Mentions - Twitter||View BCLI Investment Forum News - Investor Hub|
|View BCLI Stock Mentions - Yahoo! Message Board||View BCLI Stock Mentions - Seeking Alpha|
|View Insider Transactions for BCLI - SECform4.com||View Insider Transactions for BCLI - Insider Cow|
|View BCLI Major Holdings Summary - CNBC||View Insider Disclosure for BCLI - OTC Markets|
|View Insider Transactions for BCLI - Yahoo! Finance||View Institutional Holdings for BCLI - NASDAQ|
|View BCLI Stock Insight & Charts - FinViz.com||View BCLI Investment Charts - StockCharts.com|
|View BCLI Stock Overview & Charts - BarChart||View BCLI User Generated Charts - Trading View|
BrainStorm Cell Therapeutics to Present at the BIO Asia International Conference and the Wall Street Investor Forum
Posted on Thursday March 15, 2018
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 15, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...
BCLI: Phase 3 Trial in ALS Enrolling Patients
Posted on Tuesday March 13, 2018
BrainStorm Cell Therapeutics, Inc. (BCLI) has enrolled the first patients in the Phase 3 clinical trial of NurOwn® (NCT03280056) for the treatment of amyotrophic lateral sclerosis (ALS). Cells will be extracted from each patient one time prior to treatment, with all administrations of NurOwn® derived from the same extraction of cells thanks to a cryopreservation process developed for long-term storage of mesenchymal stem cells (MSC). The company is focusing the trial on faster-progressing ALS patients since these patients demonstrated superior outcomes in the Phase 2 trial of NurOwn®.
Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer
Posted on Tuesday March 13, 2018
Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the development ...
BrainStorm Announces Formation of Scientific Advisory Board and Appoints Neuroscientist Jerold Chun, M.D., Ph.D., to Chair
Posted on Sunday March 11, 2018
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 12, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today the formation of its Scientific Advisory Board (SAB) and the appointment of Jerold Chun, M.D., Ph.D., to Chair. Chun is an acclaimed neuroscientist and professor at Sanford Burnham Prebys Medical Discovery Institute with decades of expertise in degenerative disease research and neuroscience drug development. The SAB at BrainStorm will be composed of renowned scientists and clinical experts and will advise BrainStorm's management team on scientific matters such as research, clinical trials and drug development.